+5Kโ€
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
PEGI 3โ€
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื”ื–ื•

ืขืจื›ืช ื”ื›ืœื™ื ืœืžืœืจื™ื” ืฉืœ ืืจื’ื•ืŸ ื”ื‘ืจื™ืื•ืช ื”ืขื•ืœืžื™ (WHO) ื”ื™ื ืืคืœื™ืงืฆื™ื™ืช ื”ื”ื’ืฉื” ืœื›ืœ ืžืฉืื‘ื™ ืืจื’ื•ืŸ ื”ื‘ืจื™ืื•ืช ื”ืขื•ืœืžื™ ื”ืงืฉื•ืจื™ื ืœืžืœืจื™ื”. ื”ื•ื ืื•ืกืฃ, ื‘ืžืฉืื‘ ืื—ื“, ืืช ื›ืœ ื”ื”ื ื—ื™ื•ืช ื”ื ื•ื›ื—ื™ื•ืช ืฉืœ ืืจื’ื•ืŸ ื”ื‘ืจื™ืื•ืช ื”ืขื•ืœืžื™ ื‘ื ื•ืฉื ืžืœืจื™ื”, ื›ืžื• ื’ื ืืช ื”ืžืžืฆืื™ื, ื”ื ืชื•ื ื™ื ื•ื”ืžื’ืžื•ืช ื”ืขื“ื›ื ื™ื™ื ื‘ื™ื•ืชืจ ืž"ื“ื•ื— ื”ืžืœืจื™ื” ื”ืขื•ืœืžื™ ".
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
24 ื‘ืžืจืฅ 2025

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.
ืœื ืžืชื‘ืฆืข ืฉื™ืชื•ืฃ ื ืชื•ื ื™ื ืขื ืฆื“ื“ื™ื ืฉืœื™ืฉื™ื™ื
ื”ื ืชื•ื ื™ื ืžื•ืฆืคื ื™ื ื‘ื–ืžืŸ ื”ื”ืขื‘ืจื”

ืžื” ื—ื“ืฉ?

This version of the Guidelines includes an updated recommendation for malaria vaccines, new recommendations on the use of near-patients qualitative and semiquantitative G6PD tests to guide anti-relapse treatment of P. vivax and P. ovale, updated recommendations on primaquine and the recommendation on the use of tafenoquine.

ืชืžื™ื›ื” ื‘ืืคืœื™ืงืฆื™ื”

ืžื™ื“ืข ืขืœ ืžืคืชื—ื™ ื”ืืคืœื™ืงืฆื™ื”
Organisation Mondiale de la Santรฉ (OMS)
Avenue Appia 20 1202 Genรจve Switzerland
+41 22 791 44 43

โ€ซืขื•ื“ ืžื‘ื™ืช World Health Organizationโ€Žโ€

ืืคืœื™ืงืฆื™ื•ืช ื“ื•ืžื•ืช